{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:46:04Z","timestamp":1795056364902,"version":"4.10.2"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE2140743"],"award-info":[{"award-number":["DGE2140743"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["GM132089"],"award-info":[{"award-number":["GM132089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T15LM007092"],"award-info":[{"award-number":["T15LM007092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH\/NIAIDF32AI161793"],"award-info":[{"award-number":["NIH\/NIAIDF32AI161793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72225-x","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:47:30Z","timestamp":1777020450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Convolutional neural networks quantify antibiotic resistance in Mycobacterium tuberculosis with diagnostic grade accuracy and predict treatment response"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-610X","authenticated-orcid":false,"given":"Sanjana G.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-3682","authenticated-orcid":false,"given":"Anna G.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-7867","authenticated-orcid":false,"given":"Brendon C.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Malatesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Kulkarni-Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-3405","authenticated-orcid":false,"given":"Nina","family":"Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandukani","family":"Mulaudzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorjahn","family":"Rawoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MIC-ML Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheed Vally","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafid","family":"Soualhine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazir","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barun","family":"Mathema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Mitarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungjong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Michael","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Kreiswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"DeVos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E.","family":"Escuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitali","family":"Sintchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzaan","family":"Dippenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Heupink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C. M.","family":"Brust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-5760","authenticated-orcid":false,"given":"Maha R.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"72225_CR1","doi-asserted-by":"crossref","unstructured":"Su, M., Satola, S. W. & Read, T. D. Genome-based prediction of bacterial antibiotic resistance. J. Clin. Microbiol. 57, e01405-18 (2019).","DOI":"10.1128\/JCM.01405-18"},{"key":"72225_CR2","doi-asserted-by":"publisher","first-page":"dlad018","DOI":"10.1093\/jacamr\/dlad018","volume":"5","author":"R Banerjee","year":"2023","unstructured":"Banerjee, R. & Patel, R. Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions. JAC Antimicrob. Resist. 5, dlad018 (2023).","journal-title":"JAC Antimicrob. Resist."},{"key":"72225_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dkx506","volume":"73","author":"N Dookie","year":"2018","unstructured":"Dookie, N., Rambaran, S., Padayatchi, N., Mahomed, S. & Naidoo, K. Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J. Antimicrob. Chemother. 73, 1138\u20131151 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"72225_CR4","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/s41467-019-10110-6","volume":"10","author":"MR Farhat","year":"2019","unstructured":"Farhat, M. R., Freschi, L., Calderon, R. & Murray, M. GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. Nat. Comm. 10, 2128 (2019).","journal-title":"Nat. Comm."},{"key":"72225_CR5","doi-asserted-by":"crossref","unstructured":"Chakravorty, S. et al. The new Xpert MTB\/RIF Ultra: Improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio 8, e00812-17 (2017).","DOI":"10.1128\/mBio.00812-17"},{"key":"72225_CR6","doi-asserted-by":"publisher","first-page":"1351.e1","DOI":"10.1016\/j.cmi.2021.04.022","volume":"27","author":"A Dippenaar","year":"2021","unstructured":"Dippenaar, A. et al. Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance. Clin. Microbiol. Infect. 27, 1351.e1\u20131351.e4 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"72225_CR7","doi-asserted-by":"crossref","unstructured":"Green, A. G., Yoon, C. H., Chen, M. L., Farhat, M. R. A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis. Nat. Commun. 13, 3817 (2022).","DOI":"10.1038\/s41467-022-31236-0"},{"key":"72225_CR8","unstructured":"Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines Used in the Treatment of Drug-Resistant Tuberculosis. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-TB-2018.5 (2018)."},{"key":"72225_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2471\/BLT.11.096644","volume":"90","author":"K \u00c4ngeby","year":"2012","unstructured":"\u00c4ngeby, K., Jur\u00e9en, P., Kahlmeter, G., Hoffner, S. E. & Sch\u00f6n, T. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. Bull. World Health Organ. 90, 693\u2013698 (2012).","journal-title":"Bull. World Health Organ."},{"key":"72225_CR10","unstructured":"WHO announces updated critical concentrations for susceptibility testing to rifampicin. in World Health Organization (WHO) (2021)."},{"key":"72225_CR11","doi-asserted-by":"publisher","first-page":"e0126626","DOI":"10.1371\/journal.pone.0126626","volume":"10","author":"RE Colman","year":"2015","unstructured":"Colman, R. E. et al. Detection of low-level mixed-population drug resistance in Mycobacterium tuberculosis using high fidelity amplicon sequencing. PLoS One 10, e0126626 (2015).","journal-title":"PLoS One"},{"key":"72225_CR12","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/ng.2743","volume":"45","author":"H Safi","year":"2013","unstructured":"Safi, H. et al. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-\u03b2-D-arabinose biosynthetic and utilization pathway genes. Nat. Genet. 45, 1190\u20131197 (2013).","journal-title":"Nat. Genet."},{"key":"72225_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-59745-207-6_11","volume":"465","author":"FA Sirgel","year":"2009","unstructured":"Sirgel, F. A., Wiid, I. J. F. & van Helden, P. D. Measuring minimum inhibitory concentrations in mycobacteria. Methods Mol. Biol. 465, 173\u2013186 (2009).","journal-title":"Methods Mol. Biol."},{"key":"72225_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1715849","volume":"379","author":"R Colangeli","year":"2018","unstructured":"Colangeli, R. et al. Bacterial factors that predict relapse after tuberculosis therapy. N. Engl. J. Med. 379, 823\u2013833 (2018).","journal-title":"N. Engl. J. Med."},{"key":"72225_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/pathogens10020165","volume":"10","author":"B Kowalska-Krochmal","year":"2021","unstructured":"Kowalska-Krochmal, B. & Dudek-Wicher, R. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens 10, 165 (2021).","journal-title":"Pathogens"},{"key":"72225_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00953-4","volume":"13","author":"MI Gr\u00f6schel","year":"2021","unstructured":"Gr\u00f6schel, M. I. et al. GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning. Genome Med 13, 138 (2021).","journal-title":"Genome Med"},{"key":"72225_CR17","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1093\/bioinformatics\/bty949","volume":"35","author":"S Kouchaki","year":"2019","unstructured":"Kouchaki, S. et al. Application of machine learning techniques to tuberculosis drug resistance analysis. Bioinformatics 35, 2276\u20132282 (2019).","journal-title":"Bioinformatics"},{"key":"72225_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06449-4","volume":"12","author":"X Kuang","year":"2022","unstructured":"Kuang, X., Wang, F., Hernandez, K. M., Zhang, Z. & Grossman, R. L. Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN. Sci. Rep. 12, 2427 (2022).","journal-title":"Sci. Rep."},{"key":"72225_CR19","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.bjid.2022.102332","volume":"26","author":"A Sharma","year":"2022","unstructured":"Sharma, A., Machado, E., Lima, K. V. B., Suffys, P. N. & Concei\u00e7\u00e3o, E. C. Tuberculosis drug resistance profiling based on machine learning: A literature review. Braz. J. Infect. Dis. 26, 102332 (2022).","journal-title":"Braz. J. Infect. Dis."},{"key":"72225_CR20","doi-asserted-by":"crossref","unstructured":"Suster, C. J. E., Pham, D., Kok, J. & Sintchenko, V. Emerging applications of artificial intelligence in pathogen genomics. Front. Bacteriol. 3, 1326958 (2024).","DOI":"10.3389\/fbrio.2024.1326958"},{"key":"72225_CR21","doi-asserted-by":"publisher","first-page":"e1012260","DOI":"10.1371\/journal.pcbi.1012260","volume":"20","author":"CRyPTIC consortium","year":"2024","unstructured":"CRyPTIC consortium Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning. PLoS Comput. Biol. 20, e1012260 (2024).","journal-title":"PLoS Comput. Biol."},{"key":"72225_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-022-00396-x","volume":"16","author":"WS Alharbi","year":"2022","unstructured":"Alharbi, W. S. & Rashid, M. A review of deep learning applications in human genomics using next-generation sequencing data. Hum. Genom. 16, 26 (2022).","journal-title":"Hum. Genom."},{"key":"72225_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s12539-018-0313-4","volume":"11","author":"A Al-Ajlan","year":"2019","unstructured":"Al-Ajlan, A. & El Allali, A. CNN-MGP: Convolutional neural networks for metagenomics gene prediction. Interdiscip. Sci. 11, 628\u2013635 (2019).","journal-title":"Interdiscip. Sci."},{"key":"72225_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-09958-w","volume":"25","author":"W Hu","year":"2024","unstructured":"Hu, W., Li, M., Xiao, H. & Guan, L. Essential genes identification model based on sequence feature map and graph convolutional neural network. BMC Genom. 25, 47 (2024).","journal-title":"BMC Genom."},{"key":"72225_CR25","doi-asserted-by":"publisher","first-page":"e3001721","DOI":"10.1371\/journal.pbio.3001721","volume":"20","author":"The CRyPTIC Consortium","year":"2022","unstructured":"The CRyPTIC Consortium A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics. PLoS Biol. 20, e3001721 (2022).","journal-title":"PLoS Biol."},{"key":"72225_CR26","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1128\/IAI.00207-11","volume":"79","author":"JJ Gillespie","year":"2011","unstructured":"Gillespie, J. J. et al. PATRIC: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect. Immun. 79, 4286\u20134298 (2011).","journal-title":"Infect. Immun."},{"key":"72225_CR27","unstructured":"Catalogue of Mutations in Mycobacterium Tuberculosis Complex and Their Association with Drug Resistance, Second Edition, (2023)."},{"key":"72225_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06617-0","volume":"622","author":"NN Thadani","year":"2023","unstructured":"Thadani, N. N. et al. Learning from prepandemic data to forecast viral escape. Nature 622, 818\u2013825 (2023).","journal-title":"Nature"},{"key":"72225_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41579-025-01159-w","volume":"23","author":"GA Goig","year":"2025","unstructured":"Goig, G. A. et al. Ecology, global diversity and evolutionary mechanisms in the Mycobacterium tuberculosis complex. Nat. Rev. Microbiol. 23, 602\u2013614 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"72225_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-5615-3","volume":"20","author":"YEA Oppong","year":"2019","unstructured":"Oppong, Y. E. A. et al. Genome-wide analysis of Mycobacterium tuberculosis polymorphisms reveals lineage-specific associations with drug resistance. BMC Genom. 20, 252 (2019).","journal-title":"BMC Genom."},{"key":"72225_CR31","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/nmicrobiol.2016.41","volume":"1","author":"SG Earle","year":"2016","unstructured":"Earle, S. G. et al. Identifying lineage effects when controlling for population structure improves power in bacterial association studies. Nat. Microbiol. 1, 16041 (2016).","journal-title":"Nat. Microbiol."},{"key":"72225_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5812","volume":"5","author":"F Coll","year":"2014","unstructured":"Coll, F. et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat. Commun. 5, 4812 (2014).","journal-title":"Nat. Commun."},{"key":"72225_CR33","doi-asserted-by":"crossref","unstructured":"Humphries, R. M. et al. CLSI Methods Development and Standardization Working Group best practices for evaluation of antimicrobial susceptibility tests. J. Clin. Microbiol. 56, (2018).","DOI":"10.1128\/JCM.01934-17"},{"key":"72225_CR34","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1128\/AAC.41.9.2057","volume":"41","author":"CL Kelley","year":"1997","unstructured":"Kelley, C. L., Rouse, D. A. & Morris, S. L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41, 2057\u20132058 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72225_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1128\/AAC.41.3.600","volume":"41","author":"S Sreevatsan","year":"1997","unstructured":"Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. & Musser, J. M. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 41, 600\u2013606 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72225_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44325-5","volume":"15","author":"CRyPTIC Consortium","year":"2024","unstructured":"Consortium, C. R.yP. T. I. C. Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach. Nat. Commun. 15, 488 (2024).","journal-title":"Nat. Commun."},{"key":"72225_CR37","unstructured":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed. https:\/\/www.who.int\/publications\/i\/item\/9789240082410 (2023)."},{"key":"72225_CR38","doi-asserted-by":"crossref","unstructured":"K\u00f6ser, C. U., Georghiou, S. B., Sch\u00f6n, T. & Salfinger, M. On the consequences of poorly defined breakpoints for rifampin susceptibility testing of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 59, e02328-20 (2021).","DOI":"10.1128\/JCM.02328-20"},{"key":"72225_CR39","doi-asserted-by":"publisher","first-page":"100387","DOI":"10.1016\/j.jctube.2023.100387","volume":"33","author":"S Lale Ngema","year":"2023","unstructured":"Lale Ngema, S. et al. Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance. J. Clin. Tuberc. Other Mycobact. Dis. 33, 100387 (2023).","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"72225_CR40","unstructured":"World Health Organization. Technical Report on Critical Concentrations for Drug Susceptibility Testing of Isoniazid and the Rifamycins (rifampicin, Rifabutin and Rifapentine). Geneva: The Organization. (2021)."},{"key":"72225_CR41","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/S2666-5247(23)00252-5","volume":"5","author":"AM Garc\u00eda-Mar\u00edn","year":"2024","unstructured":"Garc\u00eda-Mar\u00edn, A. M. et al. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis. Lancet Microbe 5, e43\u2013e51 (2024).","journal-title":"Lancet Microbe"},{"key":"72225_CR42","doi-asserted-by":"crossref","unstructured":"Getis, A. & Ord, J. K. The analysis of spatial association by use of distance statistics. in Advances in Spatial Science 127\u2013145 (Springer Berlin Heidelberg, Berlin, Heidelberg, 2010).","DOI":"10.1007\/978-3-642-01976-0_10"},{"key":"72225_CR43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/jac\/dkr566","volume":"67","author":"F Maruri","year":"2012","unstructured":"Maruri, F. et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J. Antimicrob. Chemother. 67, 819\u2013831 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"72225_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tube.2017.08.001","volume":"107","author":"J Briffotaux","year":"2017","unstructured":"Briffotaux, J., Huang, W., Wang, X. & Gicquel, B. MmpS5\/MmpL5 as an efflux pump in Mycobacterium species. Tuberculosis (Edinb.) 107, 13\u201319 (2017).","journal-title":"Tuberculosis (Edinb.)"},{"key":"72225_CR45","doi-asserted-by":"publisher","first-page":"16526","DOI":"10.1074\/jbc.M113.538959","volume":"289","author":"A Radhakrishnan","year":"2014","unstructured":"Radhakrishnan, A. et al. Crystal structure of the transcriptional regulator Rv0678 of Mycobacterium tuberculosis. J. Biol. Chem. 289, 16526\u201316540 (2014).","journal-title":"J. Biol. Chem."},{"key":"72225_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41592-022-01685-y","volume":"20","author":"ML Hekkelman","year":"2023","unstructured":"Hekkelman, M. L., de Vries, I., Joosten, R. P. & Perrakis, A. AlphaFill: enriching AlphaFold models with ligands and cofactors. Nat. Methods 20, 205\u2013213 (2023).","journal-title":"Nat. Methods"},{"key":"72225_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2878","volume":"46","author":"N Casali","year":"2014","unstructured":"Casali, N. et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 46, 279\u2013286 (2014).","journal-title":"Nat. Genet."},{"key":"72225_CR48","doi-asserted-by":"crossref","unstructured":"Hicks, N. D., Carey, A. F., Yang, J., Zhao, Y. & Fortune, S. M. Bacterial genome-wide association identifies novel factors that contribute to ethionamide and prothionamide susceptibility in Mycobacterium tuberculosis. MBio 10, e00616-19 (2019).","DOI":"10.1128\/mBio.00616-19"},{"key":"72225_CR49","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.chembiol.2016.05.011","volume":"23","author":"SS Grant","year":"2016","unstructured":"Grant, S. S. et al. Baeyer-Villiger monooxygenases EthA and MymA are required for activation of replicating and non-replicating Mycobacterium tuberculosis inhibitors. Cell Chem. Biol. 23, 666\u2013677 (2016).","journal-title":"Cell Chem. Biol."},{"key":"72225_CR50","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1365-2958.2008.06365.x","volume":"69","author":"C Vilch\u00e8ze","year":"2008","unstructured":"Vilch\u00e8ze, C. et al. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol. Microbiol. 69, 1316\u20131329 (2008).","journal-title":"Mol. Microbiol."},{"key":"72225_CR51","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1128\/AAC.00020-11","volume":"55","author":"X Xu","year":"2011","unstructured":"Xu, X. et al. Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 55, 3133\u20133139 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"72225_CR52","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fmicb.2017.00710","volume":"8","author":"MLT Ang","year":"2017","unstructured":"Ang, M. L. T. et al. EthA\/R-independent killing of Mycobacterium tuberculosis by ethionamide. Front. Microbiol. 8, 710 (2017).","journal-title":"Front. Microbiol."},{"key":"72225_CR53","doi-asserted-by":"crossref","unstructured":"Vilch\u00e8ze, C. & Jacobs, W. R., Jr. Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities. Microbiol. Spectr. 2, MGM2\u20130014\u20132013 (2014).","DOI":"10.1128\/microbiolspec.MGM2-0014-2013"},{"key":"72225_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3396-y","volume":"18","author":"B Myers","year":"2018","unstructured":"Myers, B. et al. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC Infect. Dis. 18, 488 (2018).","journal-title":"BMC Infect. Dis."},{"key":"72225_CR55","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/jac\/dkae206","volume":"79","author":"M Wijk","year":"2024","unstructured":"Wijk, M. et al. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. J. Antimicrob. Chemother. 79, 2022\u20132030 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"72225_CR56","doi-asserted-by":"publisher","unstructured":"Ghanem, M. et al. Tuberculosis Disease Severity Assessment Using Clinical Variables and Radiology Enabled by Artificial Intelligence. J. Infect. Dis.https:\/\/doi.org\/10.1093\/infdis\/jiag149 (2026).","DOI":"10.1093\/infdis\/jiag149"},{"key":"72225_CR57","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3201\/eid0912.030169","volume":"9","author":"NTN Lan","year":"2003","unstructured":"Lan, N. T. N. et al. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg. Infect. Dis. 9, 1633\u20131635 (2003).","journal-title":"Emerg. Infect. Dis."},{"key":"72225_CR58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1086\/650311","volume":"201","author":"I Parwati","year":"2010","unstructured":"Parwati, I. et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J. Infect. Dis. 201, 553\u2013557 (2010).","journal-title":"J. Infect. Dis."},{"key":"72225_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1017\/S095026880500525X","volume":"134","author":"Y-J Sun","year":"2006","unstructured":"Sun, Y.-J., Lee, A. S. G., Wong, S.-Y. & Paton, N. I. Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiol. Infect. 134, 329\u2013332 (2006).","journal-title":"Epidemiol. Infect."},{"key":"72225_CR60","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/infdis\/jit048","volume":"207","author":"MNT Huyen","year":"2013","unstructured":"Huyen, M. N. T. et al. Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections. J. Infect. Dis. 207, 1516\u20131524 (2013).","journal-title":"J. Infect. Dis."},{"key":"72225_CR61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S2213-2600(15)00036-3","volume":"3","author":"EV Kurbatova","year":"2015","unstructured":"Kurbatova, E. V. et al. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Lancet Respir. Med. 3, 201\u2013209 (2015).","journal-title":"Lancet Respir. Med."},{"key":"72225_CR62","doi-asserted-by":"publisher","first-page":"e0197880","DOI":"10.1371\/journal.pone.0197880","volume":"13","author":"KA Alene","year":"2018","unstructured":"Alene, K. A. et al. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis. PLoS One 13, e0197880 (2018).","journal-title":"PLoS One"},{"key":"72225_CR63","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1164\/rccm.200210-1125OC","volume":"167","author":"A Jindani","year":"2003","unstructured":"Jindani, A., Dor\u00e9, C. J. & Mitchison, D. A. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am. J. Respir. Crit. Care Med 167, 1348\u20131354 (2003).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"72225_CR64","doi-asserted-by":"crossref","unstructured":"Tornheim, J. A. & Dooley, K. E. Tuberculosis associated with HIV infection. Microbiol. Spectr. 5, 1128 (2017).","DOI":"10.1128\/microbiolspec.TNMI7-0028-2016"},{"key":"72225_CR65","doi-asserted-by":"publisher","first-page":"a017871","DOI":"10.1101\/cshperspect.a017871","volume":"5","author":"J Bruchfeld","year":"2015","unstructured":"Bruchfeld, J., Correia-Neves, M. & K\u00e4llenius, G. Tuberculosis and HIV coinfection. Cold Spring Harb. Perspect. Med. 5, a017871 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"72225_CR66","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/jcc.26979","volume":"43","author":"AE Brankin","year":"2022","unstructured":"Brankin, A. E. & Fowler, P. W. Predicting antibiotic resistance in complex protein targets using alchemical free energy methods. J. Comput. Chem. 43, 1771\u20131782 (2022).","journal-title":"J. Comput. Chem."},{"key":"72225_CR67","unstructured":"GenoScreen (2022). Deeplex\u00ae Myc-TB: From Clinical Samples to Drug Resistance Profile https:\/\/www.genoscreen.fr\/images\/genoscreen-services\/deeplex\/technical_note_20221221_RUO-avec_compression_1.pdf."},{"key":"72225_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53273-7","volume":"15","author":"VK Chang","year":"2024","unstructured":"Chang, V. K. et al. Risk-stratified treatment for drug-susceptible pulmonary tuberculosis. Nat. Commun. 15, 9400 (2024).","journal-title":"Nat. Commun."},{"key":"72225_CR69","doi-asserted-by":"publisher","first-page":"1331371","DOI":"10.3389\/fphar.2023.1331371","volume":"14","author":"M Zhou","year":"2023","unstructured":"Zhou, M. et al. The efficacy and safety of high-dose isoniazid-containing therapy for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Front. Pharmacol. 14, 1331371 (2023).","journal-title":"Front. Pharmacol."},{"key":"72225_CR70","unstructured":"WHO launches new guidance on the use of targeted next-generation sequencing tests for the diagnosis of drug-resistant TB and a new sequencing portal. https:\/\/www.who.int\/news\/item\/20-03-2024-who-launches-new-guidance-on-the-use-of-targeted-next-generation-sequencing-tests-for-the-diagnosis-of-drug-resistant-tb-and-a-new-sequencing-portal. (2024)."},{"key":"72225_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaf219","volume":"41","author":"MG Marin","year":"2025","unstructured":"Marin, M. G. et al. Pitfalls of bacterial pan-genome analysis approaches: a case study of Mycobacterium tuberculosis and two less clonal bacterial species. Bioinformatics 41, btaf219 (2025).","journal-title":"Bioinformatics"},{"key":"72225_CR72","doi-asserted-by":"crossref","unstructured":"Wyllie, D. H. et al. Identifying mixed Mycobacterium tuberculosis infection and laboratory cross-contamination during mycobacterial sequencing programs. J. Clin. Microbiol. 56, (2018).","DOI":"10.1128\/JCM.00923-18"},{"key":"72225_CR73","doi-asserted-by":"crossref","unstructured":"Naz, S. et al. GWAS and functional studies suggest a role for altered DNA repair in the evolution of drug resistance in Mycobacterium tuberculosis. Elife 12, e75860 (2023).","DOI":"10.7554\/eLife.75860"},{"key":"72225_CR74","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/microorganisms10071440","volume":"10","author":"D Lagutkin","year":"2022","unstructured":"Lagutkin, D. et al. Genome-Wide Study of Drug Resistant Mycobacterium tuberculosis and Its Intra-Host Evolution during Treatment. Microorganisms 10, 1440 (2022).","journal-title":"Microorganisms"},{"key":"72225_CR75","doi-asserted-by":"publisher","first-page":"e3001755","DOI":"10.1371\/journal.pbio.3001755","volume":"20","author":"The CRyPTIC Consortium","year":"2022","unstructured":"The CRyPTIC Consortium The CRyPTIC Consortium. Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms. PLoS Biol. 20, e3001755 (2022).","journal-title":"PLoS Biol."},{"key":"72225_CR76","unstructured":"Shrikumar, A., Greenside, P. & Kundaje, A. Learning important features through propagating activation differences. arXiv [cs.CV] (2017)."},{"key":"72225_CR77","doi-asserted-by":"publisher","unstructured":"Ancona, M., Ceolini, E., \u00d6ztireli, C. & Gross, M. Towards better understanding of gradient-based attribution methods for Deep Neural Networks. Preprint at arXiv https:\/\/doi.org\/10.48550\/arXiv.1711.06104 (2017).","DOI":"10.48550\/arXiv.1711.06104"},{"key":"72225_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01782-8","volume":"22","author":"S Malatesta","year":"2022","unstructured":"Malatesta, S. et al. Methods for handling missing data in serially sampled sputum specimens for mycobacterial culture conversion calculation. BMC Med. Res. Methodol. 22, 297 (2022).","journal-title":"BMC Med. Res. Methodol."},{"key":"72225_CR79","unstructured":"Rubin, D. B. et al. Multiple Imputation for Nonresponse in Surveys. (John Wiley & Sons, Nashville, TN, 2009)."},{"key":"72225_CR80","first-page":"1034","volume":"79","author":"S Prakash Babu","year":"2024","unstructured":"Prakash Babu, S. et al. Factors associated with unfavorable treatment outcomes among persons with pulmonary tuberculosis: A multicentric prospective cohort study from India. Clin. Infect. Dis. 79, 1034\u20131038 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"72225_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58080-0","volume":"14","author":"LW Limenh","year":"2024","unstructured":"Limenh, L. W. et al. Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta Town, Northwest Ethiopia: a five-year retrospective study. Sci. Rep. 14, 7695 (2024).","journal-title":"Sci. Rep."},{"key":"72225_CR82","doi-asserted-by":"publisher","first-page":"e0226507","DOI":"10.1371\/journal.pone.0226507","volume":"14","author":"NM Chaves Torres","year":"2019","unstructured":"Chaves Torres, N. M., Quijano Rodr\u00edguez, J. J., Porras Andrade, P. S., Arriaga, M. B. & Netto, E. M. Factors predictive of the success of tuberculosis treatment: a systematic review with meta-analysis. PLoS One 14, e0226507 (2019).","journal-title":"PLoS One"},{"key":"72225_CR83","doi-asserted-by":"publisher","first-page":"e1005641","DOI":"10.1371\/journal.pgen.1005641","volume":"11","author":"SS Shell","year":"2015","unstructured":"Shell, S. S. et al. Leaderless transcripts and small proteins are common features of the mycobacterial translational landscape. PLoS Genet 11, e1005641 (2015).","journal-title":"PLoS Genet"},{"key":"72225_CR84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tube.2010.09.006","volume":"91","author":"A Kapopoulou","year":"2011","unstructured":"Kapopoulou, A., Lew, J. M. & Cole, S. T. The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomes. Tuberculosis (Edinb.) 91, 8\u201313 (2011).","journal-title":"Tuberculosis (Edinb.)"},{"key":"72225_CR85","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","volume":"16","author":"S Gagneux","year":"2018","unstructured":"Gagneux, S. Ecology and evolution of Mycobacterium tuberculosis. Nat. Rev. Microbiol. 16, 202\u2013213 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"72225_CR86","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nm0696-662","volume":"2","author":"A Scorpio","year":"1996","unstructured":"Scorpio, A. & Zhang, Y. Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2, 662\u2013667 (1996).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72225-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72225-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72225-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:02:47Z","timestamp":1782777767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72225-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72225"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72225-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5667"}}